deltatrials

Mycobacterium avium-intracellulare infection Trials in Baltimore, United States

Conditions / Mycobacterium avium-intracellulare infection / Baltimore, United States

Mycobacterium avium-intracellulare infection is a medical condition with active clinical research programs worldwide.

10 total trials for this combination

Trials

NCT ID Title Status Phase
NCT00001023 The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients COMPLETED NA
NCT00000883 Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy COMPLETED NA
NCT00000860 The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients COMPLETED
NCT00001047 Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS COMPLETED PHASE3
NCT00000644 A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS COMPLETED PHASE2
NCT00002032 Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial COMPLETED NA
NCT00001039 Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients COMPLETED PHASE2
NCT00000907 A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients COMPLETED
NCT00001030 The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients COMPLETED PHASE3
NCT00001058 A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS COMPLETED PHASE2

Related Pages